Caroline Tillett - 15 Dec 2025 Form 4 Insider Report for Kenvue Inc. (KVUE)

Role: Chief Scientific Officer
Signature: /s/ Alla Berenshteyn, as attorney-in-fact
Issuer symbol: KVUE
Transactions as of: 15 Dec 2025
Net transactions value: -$299,599
Form type: 4
Filing time: 17 Dec 2025, 17:48:25 UTC
Previous filing: 03 Dec 2025
Next filing: 04 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Tillett Caroline	Chief Scientific Officer	1 KENVUE WAY, SUMMIT	/s/ Alla Berenshteyn, as attorney-in-fact	17 Dec 2025	0001966949

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KVUE	Common Stock	Options Exercise	$0	+23,158	+52%	$0.000000	68,038	15 Dec 2025	Direct
transaction	KVUE	Common Stock	Tax liability	$204,699	-11,846	-17%	$17.28	56,192	15 Dec 2025	Direct	F1
transaction	KVUE	Common Stock	Options Exercise	$0	+2,994	+5.3%	$0.000000	59,186	15 Dec 2025	Direct
transaction	KVUE	Common Stock	Tax liability	$26,473	-1,532	-2.6%	$17.28	57,654	15 Dec 2025	Direct	F1
transaction	KVUE	Common Stock	Options Exercise	$0	+4,399	+7.6%	$0.000000	62,053	15 Dec 2025	Direct
transaction	KVUE	Common Stock	Tax liability	$38,740	-2,251	-3.6%	$17.21	59,802	15 Dec 2025	Direct	F1
transaction	KVUE	Common Stock	Options Exercise	$0	+3,372	+5.6%	$0.000000	63,173	15 Dec 2025	Direct
transaction	KVUE	Common Stock	Tax liability	$29,687	-1,725	-2.7%	$17.21	61,448	15 Dec 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KVUE	Restricted Stock Units	Options Exercise	$0	-23,158	-100%	$0.000000	0	15 Dec 2025	Common Stock	23,158		Direct	F2, F3, F4
transaction	KVUE	Restricted Stock Units	Options Exercise	$0	-2,994	-100%	$0.000000	0	15 Dec 2025	Common Stock	2,994		Direct	F4, F5, F6
transaction	KVUE	Restricted Stock Units	Options Exercise	$0	-4,399	-50%	$0.000000	4,399	15 Dec 2025	Common Stock	4,399		Direct	F4, F7, F8, F9
transaction	KVUE	Restricted Stock Units	Options Exercise	$0	-3,372	-33%	$0.000000	6,740	15 Dec 2025	Common Stock	3,372		Direct	F4, F7, F9, F10

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares withheld for payment of taxes upon vesting of Restricted Stock Units ("RSUs").
F2	These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 2023, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level.
F3	This award was scheduled to vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date but vesting was accelerated in order to mitigate the adverse impact to the Issuer and the Reporting Person of Section 280G of the Internal Revenue Code in connection with the pending transaction between the Issuer and Kimberly-Clark Corporation ("Section 280G Mitigation").
F4	This award will be subject to clawback in the event it is determined that the Reporting Person would not have ultimately vested in the award notwithstanding the acceleration reflected herein.
F5	These RSUs were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer, were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.
F6	This award was scheduled to vest in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date but the vesting of the portion reflected herein was accelerated from 02/13/2026 in connection with the Section 280G Mitigation.
F7	These units correspond 1 for 1 with the Company's common stock.
F8	This award was scheduled to vest in three equal installments on 03/05/2025, 03/05/2026, and 03/05/2027, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/05/2026 in connection with the 280G Mitigation.
F9	Includes RSUs acquired as dividend equivalents.
F10	This award was scheduled to vest in three equal installments on 03/10/2026, 03/10/2027, and 03/10/2028, subject to the reporting person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated from 03/10/2026 in connection with the Section 280G Mitigation.